ON Semiconductor’s Stock Tanks After Q3 Performance – Here’s Why

ON Semiconductor Corp (NASDAQ: ON) stock reported a third-quarter FY23 revenue decline of 0.5% year-on-year to $2.18 billion, beating the 

ON Semiconductor Corp (NASDAQ:ON) stock reported a third-quarter FY23 revenue decline of 0.5% year-on-year to $2.18 billion, beating the consensus of $2.15 billion. 

The Intel Corp (NASDAQ:INTC) rival’s adjusted EPS of $1.39 beat the consensus of $1.34.

Revenue from Power Solutions Group (PSG) grew 10% Y/Y to $1.23 billion, Advanced Solutions Group (ASG) decreased 15% Y/Y to $621.6 million, and Intelligent Sensing Group (ISG) fell by 4% Y/Y to $328.6 million.

The adjusted gross margin declined by 200 bps to 47.3%, and the adjusted operating margin decreased by 280 bps to 32.6%.

ON Semiconductor generated $133.6 million in free cash flow and held $2.68 billion in cash and equivalents.

CEO Hassane El-Khoury said, “We continue to drive structural improvements and efficiencies, most notably in our silicon carbide operation, with the completed expansion of the world’s largest, state-of-the-art silicon carbide fab in South Korea for 150- and 200-millimeter wafers.”

Outlook: ON Semiconductor expects fourth-quarter adjusted revenue of $1.95 billion – $2.05 billion, below the consensus of $2.18 billion.

The company sees non-GAAP EPS of $1.13 – $1.27 versus the consensus of $1.36.

ON Price Action: ON Semiconductor shares are trading lower by 19.80% at $66.94 on the last check Monday.

Total
0
Shares
Related Posts
Read More

Reported Late Thursday, Avalo Therapeutics Announces Pricing Of $15M Public Offering Of 3.77M Shares Of Common Stock And Warrants To Purchase 3.77M Shares Of Stock At A Price Of $3.98/ Share & Warrant, 1-Year Term Excursive Price Of $5/Share

Avalo Therapeutics, Inc. (NASDAQ:AVTX) (Avalo) announced today the pricing of an underwritten public offering of 3,770,000 shares of its common stock and warrants to purchase up to an aggregate of 3,770,000 shares

AVTX